Series C - Circle Pharma - 2021-06-16 - Crunchbase

Jun 16, 2021 · Circle Pharma raised $66000000 on 2021-06-16 in Series C. Nextech Invest Nextech Invest is a venture capital and private equity firm specializing in early, mid-stage, late …

CouponFollow Extension

$66000000
OFF

Series C - Circle Pharma - 2021-06-16 - Crunchbase

1 week from now

Jun 16, 2021 · Circle Pharma raised $66000000 on 2021-06-16 in Series C. Nextech Invest Nextech Invest is a venture capital and private equity firm specializing in early, mid-stage, late …

crunchbase.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Jun 16, 2021 · Read original article at Business Wire. South San Francisco, CA, June 16, 2021, — Circle Pharma, Inc., a macrocycle drug discovery and development company focused on …

circlepharma.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Jun 16, 2021 · Circle Pharma has raised a $66M Series C financing to advance its precision oncology programs. Circle Pharma Raises $66 Million in Series C Financing June 16, 2021 …

businesswire.com

$66
OFF

Wilson Sonsini Advises Circle Pharma On $66 Million Series C …

1 week from now

On June 16, 2021, Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, announced that it has raised $66 million in an …

wsgr.com

$66
OFF

Alliance Of Chief Executives - Circle Pharma Raises $66 Million In ...

1 week from now

June 16, 2021. SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, …

allianceofceos.com

$66
OFF

Lilly Helps Circle Round Up $66M For Intractable Target R&D

1 week from now

Jun 17, 2021 · Circle Pharma has raised $66 million to take cyclin-targeted programs toward clinical development. The Eli Lilly-backed series C round sets Circle up to build on its years of …

fiercebiotech.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Jun 16, 2021 · Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced that it has raised $66 million in an …

marketscreener.com

$66
OFF

Circle Pharma Raises $66M In Series C Financing - FinSMEs

1 week from now

Jun 16, 2021 · Circle Pharma, Inc., a South San Francisco, Calif.-based macrocycle drug discovery and development company focused on intractable cancer targets, raised $66m in …

finsmes.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Jun 16, 2021 · Circle Pharma, Inc.today announced that it has raised $66 million in an oversubscribed Series C financing. June 16, 2021 21:00 UTC SOUTH SAN FRANCISCO, …

biospace.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

Circle Pharma raises $66 Million in Series C Financing. On June 16, 2021 Circle Pharma, Inc., ... Circle’s President and CEO. "The funding will help drive our progress to the clinic and support …

1stoncology.com

$66
OFF

Circle Pharma Raises $66 Million In Series C Financing

1 week from now

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, today announced …

mbn.media

$66
OFF

Wilson Sonsini Advises Circle Pharma On $66 Million Series C …

1 week from now

On June 16, 2021, Circle Pharma, Inc., a macrocycle drug discovery and development company focused on intractable cancer targets, announced that it has raised $66 million in an …

wsgr.com

$90
OFF

The Week’s 10 Biggest Funding Rounds: Safe Superintelligence …

1 week from now

Sep 6, 2024 · Circle Pharma, $90M, biotech: South San Francisco-based Circle Pharma, a biotech company developing cell-permeable macrocycles for therapies, closed a $90 million …

crunchbase.com

$45000000
OFF

Series B - Circle Pharma - 2020-03-17 - Crunchbase Funding …

1 week from now

Mar 17, 2020 · Circle Pharma raised $45000000 on 2020-03-17 in Series B. Search Crunchbase ... Save . Summary. Overview. Edit Overview Section. Organization Name . Circle Pharma . …

crunchbase.com

$90000000
OFF

Series D - Circle Pharma - 2024-09-03 - Crunchbase Funding …

1 week from now

Sep 3, 2024 · Circle Pharma raised $90000000 on 2024-09-03 in Series D. Search Crunchbase ... Closed On Date Sep 3, 2024; Funding Type Series D; Funding Stage Late Stage Venture; …

crunchbase.com

$209800000
OFF

Series C - Cribl - 2021-08-25 - Crunchbase Funding Round Profile

1 week from now

Aug 25, 2021 · Cribl raised $209800000 on 2021-08-25 in Series C. Search Crunchbase. Start Free Trial . Chrome Extension ... Save . Summary. Overview. Edit Overview Section. …

crunchbase.com

FAQs about Series C - Circle Pharma - 2021-06-16 - Crunchbase Coupon?

Is circle Pharma a biotech?

Circle Pharma, $90M, biotech: South San Francisco-based Circle Pharma, a biotech company developing cell-permeable macrocycles for therapies, closed a $90 million Series D — which includes the conversion of a convertible note — led by The Column Group. Founded in 2012, the company has raised nearly $208 million, per Crunchbase. ...

What is circle Pharma doing with cyclin-targeted peptides?

Circle Pharma has raised $66 million to take cyclin-targeted programs toward clinical development. The Eli Lilly-backed series C round sets Circle up to build on its years of research into cell-permeable macrocyclic peptide therapeutics with the potential to hit previously undruggable targets. ...

What is a circle drug & how does it work?

Specifically, Circle sees its drugs as ways to hit targets that lack binding sites for small molecules and are hidden from biologics inside cells. Unlike those modalities, macrocycles may be able to enter cells to inhibit processes such as protein-protein interactions. ...